|
General Information
|
|
|
Product
|
PCSK9 Peptide
|
|
Description
|
Antigenic Blocking Peptide Proprotein convertase subtilisin/kexin type 9
|
|
Verified Applications
|
Immunocompetition, Immunodepletion
|
|
Peptide Description
|
Synthetic peptide taken within amino acid region 30-60 on the NARC1 protein.
|
|
Accession #
|
NCBI: NP_705793.1
|
|
Physical Properties
|
|
|
Quantity
|
250 µg
|
|
Volume
|
100 µl
|
|
Form
|
Antigenic Blocking Peptide
|
|
Storage
|
-20⁰C for long term storage
|
|
Application Protocol
|
|
Competition/Depletion assay
|
Refer to competition assay protocol
|
|
Protein
|
|
Uniprot #
|
Q80W65
|
|
Overview
|
Crucial player in the regulation of plasma cholesterol homeostasis
|
|
Molecular Function
|
Hydrolase, Protease, Serine protease
|
|
Subcellular Location
|
Cytoplasm, Endoplasmic reticulum, Endosome, Golgi apparatus, Lysosome, Secreted
|
|
Expression
|
Hepatocytes, kidney mesenchymal cells, intestinal ileum, colon epithelia and embryonic brain telencephalon neurons.
|
|
Structure
|
Monomer. Can self-associate to form dimers and higher multimers,Belongs to the peptidase S8 family
|
|
Alternative Nomenclature
|
Convertase subtilisin/kexin type 9 preproprotein antibody
FH3 antibody
HCHOLA3 antibody
LDLCQ1 antibody
NARC 1 antibody
PC 9 antibody
PCSK9 antibody
PSEC0052 antibody
|
| |
|
PCSK9 Antibody
PCSK9 Antibody FITC
PCSK9 Antibody BIOTIN
PCSK9 Positive Control
